Concert Pharma (CNCE) Reports Q1 Loss of $0.93/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Concert Pharmaceuticals Reports First Quarter 2019 Financial Results
May 2, 2019 7:00 AM EDTConference Call Scheduled Today at 8:30 a.m. ET
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2019.
The progress we are making to advance our pipeline positions us for a series of significant data readouts in 2019, said Roger Tung, Ph.D.,... More
